Literature DB >> 8877079

Reversal of Borrelia burgdorferi associated dilated cardiomyopathy by antibiotic treatment?

R Gasser1, F Fruhwald, M Schumacher, G Seinost, E Reisinger, B Eber, A Keplinger, R Horvath, B Sedaj, W Klein, K Pierer.   

Abstract

It is suggested that Borrelia burgdorferi infection could be associated with dilated cardiomyopathy (IDC). Stanek et al. were able to cultivate Borrelia burgdorferi from myocardial biopsy tissue of a patient with longstanding dilated cardiomyopathy. Here we present a study in which we examined the effect of standard antibiotic treatment on the left ventricular ejection fraction (LVEF) in patients with dilated cardiomyopathy associated with Borrelia burgdorferi infection. In this study we assessed the serum (IgG, IgM Elisa) and history of 46 IDC patients with specific regard to Borrelia burgdorferi infection (mean LVEF 30.4 +/- 1.3%, measured by cardiac catheterization and echocardiography with the length-area-volume method). All 46 patients received standard treatment for dilated cardiomyopathy: ACE inhibitors, digitalis, and diuretics. Eleven (24%) patients showed positive serology and a history of Borrelia burgdorferi infection; nine of these also had a typical history of tick bite and erythema chronicum migrans (ECM) and/or other organ involvement, and two had no recollection of tick bite or ECM but showed other Borrelia burgdorferi-associated disorders (neuropathy, oligoarthritis). These 11 patients with Borrelia burgdorferi infection received standard antibiotic treatment with intravenous ceftriaxone 2 g bid for 14 days. Six (55%) recovered completely and showed a normal LVEF after 6 months, three (27%) improved their LVEF, and two (18%) did not improve at all. This amounts to nine (82%) patients with recovery/improvement in the Borrelia burgdorferi group. The 35 patients who did not show positive serology or a history of Borrelia burgdorferi infection did not receive antibiotic treatment. In this group without Borrelia burgdorferi infection 12 (26%), showed recovery/improvement following the standard treatment of dilated cardiomyopathy (see earlier). Our results indicate that Borrelia burgdorferi infection could play a decisive role in the development of dilated cardiomyopathy, especially in a geographical region such as Graz, where Borrelia burgdorferi is endemic. While we are aware of the small number of Borrelia burgdorferi patients in this study, we nevertheless conclude that in a remarkable number of patients with signs of Borrelia burgdorferi infection, dilated cardiomyopathy could be reversed and LVEF improved.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877079     DOI: 10.1007/bf02627960

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  41 in total

1.  Ventricular tachycardia associated with Lyme carditis.

Authors:  S C Vlay; J P Dervan; J Elias; P P Kane; R Dattwyler
Journal:  Am Heart J       Date:  1991-05       Impact factor: 4.749

2.  Problems in the use of serologic tests for the diagnosis of Lyme disease.

Authors:  M Corpuz; E Hilton; M P Lardis; C Singer; J Zolan
Journal:  Arch Intern Med       Date:  1991-09

Review 3.  Idiopathic cardiomyopathy in the United States, 1970-1982.

Authors:  R F Gillum
Journal:  Am Heart J       Date:  1986-04       Impact factor: 4.749

4.  Ceftriaxone as effective therapy in refractory Lyme disease.

Authors:  R J Dattwyler; J J Halperin; H Pass; B J Luft
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

5.  Treatment of the early manifestations of Lyme disease.

Authors:  A C Steere; G J Hutchinson; D W Rahn; L H Sigal; J E Craft; E T DeSanna; S E Malawista
Journal:  Ann Intern Med       Date:  1983-07       Impact factor: 25.391

6.  Echoventriculography -- a simultaneous analysis of two-dimensional echocardiography and cineventriculography.

Authors:  R Erbel; P Schweizer; H Lambertz; G Henn; J Meyer; W Krebs; S Effert
Journal:  Circulation       Date:  1983-01       Impact factor: 29.690

7.  Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies.

Authors: 
Journal:  Br Heart J       Date:  1980-12

8.  In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.

Authors:  R C Johnson; C Kodner; M Russell
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

9.  Lyme borreliosis as a cause of myocarditis and heart muscle disease.

Authors:  J Klein; G Stanek; R Bittner; R Horvat; C Holzinger; D Glogar
Journal:  Eur Heart J       Date:  1991-08       Impact factor: 29.983

Review 10.  Lyme borreliosis: ten years after discovery of the etiologic agent, Borrelia burgdorferi.

Authors:  W Burgdorfer
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

View more
  2 in total

1.  Update on Lyme Carditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

2.  Suspected inflammatory cardiomyopathy. Prevalence of Borrelia burgdorferi in endomyocardial biopsies with positive serological evidence.

Authors:  K Karatolios; B Maisch; S Pankuweit
Journal:  Herz       Date:  2014-06-19       Impact factor: 1.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.